🔴 Pacific Biosciences is trading 5% down today; catalyst remains unclear

Pacific Biosciences is trading 5.01% down at $1.28, with no new company-specific announcement identified to explain the August 24, 2026 decline.

• Recent coverage highlights broader biotechnology strength, while major indexes are only modestly mixed.
• Earlier Q2 revenue misses, reduced guidance, and delayed breakeven expectations were reported August 5, not as a fresh August 24 event.